Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.1% |
| 2 | Technology | 1.55% |
| 3 | Consumer Discretionary | 0.95% |
| 4 | Financials | 0.77% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRVG
11276
trivago
TRVG
$423M
| $142K | ﹤0.01% |
34,657
-6,570
| -16% | -$24.2K |
|
|
BFZ
11277
DELISTED
BlackRock CA Municipal Income Trust
BFZ
| $142K | ﹤0.01% |
12,889
+737
| +6% | +$8.28K |
|
11278
Orchestra BioMed
OBIO
$311M
| $141K | ﹤0.01% |
32,988
+20,819
| +171% | +$104K |
|
|
PFD
11279
Flaherty & Crumrine Preferred and Income Fund
PFD
$145M
| $141K | ﹤0.01% |
12,539
+1,560
| +14% | +$17.6K |
|
11280
CALL
Immunome
IMNM
$3.13B
| $141K | ﹤0.01% |
20,900
+3,300
| +19% | +$31.7K |
|
11281
PUT
Kura Oncology
KURA
$1.13B
| $141K | ﹤0.01% |
21,300
-48,000
| -69% | -$374K |
|
11282
CALL
Pliant Therapeutics
PLRX
$68.7M
| $140K | ﹤0.01% |
103,900
+30,200
| +41% | +$183K |
|
11283
Fate Therapeutics
FATE
$291M
| $140K | ﹤0.01% |
177,360
+69,946
| +65% | +$85.7K |
|
11284
Hafnia
HAFN
$4.23B
| $140K | ﹤0.01% |
+33,618
| New | +$166K |
|
11285
Empire Petroleum
EP
$134M
| $140K | ﹤0.01% |
22,237
+10,481
| +89% | +$67.3K |
|
|
WIMI
11286
WiMi Hologram Cloud
WIMI
$23.9M
| $140K | ﹤0.01% |
14,343
-19,494
| -58% | -$187K |
|
|
DENN
11287
PUT
DELISTED
Denny's
DENN
| $139K | ﹤0.01% |
+38,000
| New | +$200K |
|
11288
Unusual Machines
UMAC
$1.2B
| $139K | ﹤0.01% |
+21,747
| New | +$220K |
|
|
MTR
11289
Mesa Royalty Trust
MTR
$4.17M
| $139K | ﹤0.01% |
22,335
+3,423
| +18% | +$22K |
|
11290
PUT
TriplePoint Venture Growth BDC
TPVG
$221M
| $139K | ﹤0.01% |
19,900
-15,800
| -44% | -$121K |
|
11291
Sera Prognostics
SERA
$81.7M
| $139K | ﹤0.01% |
37,699
-64,761
| -63% | -$330K |
|
11292
CALL
Motorcar Parts of America
MPAA
$218M
| $139K | ﹤0.01% |
+14,600
| New | +$127K |
|
11293
BlackRock MuniHoldings New Jersey Quality Fund
MUJ
$639M
| $138K | ﹤0.01% |
+12,293
| New | +$140K |
|
|
IRS
11294
IRSA Inversiones y Representaciones
IRS
$1.24B
| $137K | ﹤0.01% |
+10,655
| New | +$151K |
|
11295
CALL
Hagerty
HGTY
$1.37B
| $137K | ﹤0.01% |
15,200
-10,200
| -40% | -$98.9K |
|
|
TRT
11296
Trio-Tech International
TRT
$102M
| $137K | ﹤0.01% |
45,806
+7,432
| +19% | +$22.5K |
|
|
IMDX
11297
Insight Molecular Diagnostics
IMDX
$135M
| $137K | ﹤0.01% |
+44,806
| New | +$121K |
|
11298
PUT
SES AI
SES
$194M
| $137K | ﹤0.01% |
263,300
+205,100
| +352% | +$189K |
|
11299
PUT
Cato Corp
CATO
$52.9M
| $137K | ﹤0.01% |
41,100
-2,800
| -6% | -$9.4K |
|
11300
BlackRock MuniYield Quality Fund
MQY
$795M
| $137K | ﹤0.01% |
11,684
-46,954
| -80% | -$556K |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q1 2025 filing shows 1,775 new, 5,712 increased, 4,842 reduced and 1,482 closed positions. Its largest new stake was Brookfield Asset Management: 1,775,684 shares worth $86M. The largest sale was Invesco QQQ Trust, an estimated $1.25B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.